Skip to main content

Table 2 Numbers of individuals needed to be treated with an 8-aminoquinoline to prevent one P. vivax infection, assuming 99% P. vivax radical cure rate adjusted for correlation among qPCR test result from same individual

From: The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos

Plasmodium parasites detected in the preceding survey

Number of no subsequent P. vivax infection, n/N

Probability of no subsequent P. vivax infection (95% CI)

Probability no subsequent P. vivax with radical cure assumed

RD (95% CI) with 99% P. vivax radical cure

NNT (95% CI)

P. falciparum (monoinfection)

487/534

0.090 (0.068, 0.119)

0.99

0.080 (0.045, 0.116)

12 (9, 22)

P. falciparum + P. vivax (mixed infection)

113/217

0.466 (0.402, 0.540)

0.99

0.456 (0.359, 0.553)

2 (2, 3)

P. vivax (monoinfection)

585/1169

0.447 (0.416, 0.480)

0.99

0.437 (0.392, 0.482)

2 (2, 3)

Negative

14,524/15,039

0.036 (0.033, 0.039)

0.99

0.026 (0.022, 0.031)

38 (33, 46)

  1. RD risk difference, NNT number needed to treat